biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24th, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) has appointed Mark Day, Ph.D., as President and Chief Executive Officer of the Company, effective immediately. Dr. Day succeeds Mr. Rob Hutchison who will become Executive Chairman [...]

By | Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

biOasis Announces Investor Relations Service Agreement

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) The Company announces that it has entered into an investor relations agreement (“Agreement”) with 551943 Alberta Ltd., operating as Colwell Capital Corp (“Colwell”), for a maximum term [...]

By | Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

BIOASIS ANNOUNCES GRANT OF STOCK OPTIONS AND RESTRICTED STOCK UNITS

THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF April 24, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that pursuant to the terms of its stock option plan (the “Option Plan”) and restricted stock units plan (the “RSU Plan”), the Company [...]

By | Tuesday, April 25, 2017|2017 Press Releases, Corporate Press Releases|

biOasis Announces Oversubscription of Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF March 31st, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that further to its press release dated March 20, 2017, the Company’s non-brokered private placement (the "Private Placement"), is [...]

By | Friday, March 31, 2017|2017 Press Releases, Corporate Press Releases|

biOasis Announces Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Download this as a PDF March 20th, 2017, Vancouver, BC biOasis Technologies Inc. (TSX.V: BTI) (the “Company”) announces a nonbrokered private placement of up to 4,500,000 units at a price of $0.70 per unit of gross proceeds of up to [...]

By | Monday, March 20, 2017|2017 Press Releases, Corporate Press Releases|

biOasis Provides AGM Update – Expanding The biOasis Deal Flow Pipeline

Download this as a PDF January 23rd, 2017, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pioneering biopharmaceutical company focused on the delivery of therapeutic drugs across the blood-brain barrier (BBB), has provided a corporate update in advance of its Annual and Special Meeting of Shareholders to be held at 1780 - 400 Burrard Street, [...]

By | Monday, January 23, 2017|2017 Press Releases, Corporate Press Releases|

biOasis Announces Adoption of Restricted Share Unit Plan

Download this as a PDF December 22nd, 2016, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) announces that subject to approval by the TSX Venture Exchange ("TSXV") and ratification by the Company's shareholders at the 2016 Annual and Special General Meeting of shareholders (the "AGM"), the Company adopted a restricted share unit plan (the [...]

By | Friday, December 23, 2016|2016 Press Releases, Corporate Press Releases, Uncategorized|

biOasis Attends BIO Europe and the Lockman BT2111 Paper is Honored by being Featured on the Cover of Pharmaceutical Research’s December Journal

Download this as a PDF November 6th, 2016, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), today announced it’s team is attending BIO Europe, November 7th to 9th, in Cologne, Germany. In addition, the company announced that Dr. [...]

By | Monday, November 7, 2016|2016 Press Releases, Corporate Press Releases|

biOasis Engages Rising Tide Equity to Increase Global Awareness

Download this as a PDF October 23rd, 2016, Vancouver, BC BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), today announced it has engaged Rising Tide Equity to increase its global awareness. Investors are increasingly using digital media and non-traditional media [...]

By | Tuesday, October 25, 2016|2016 Press Releases, Corporate Press Releases|